1999
DOI: 10.1093/ndt/14.10.2461
|View full text |Cite
|
Sign up to set email alerts
|

Chronic graft-versus-host disease complicated by membranous glomerulonephritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
29
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(30 citation statements)
references
References 4 publications
1
29
0
Order By: Relevance
“…[16][17][18][19][20][21][22][23][24][25][26][27][28] In all these reports, similar to our series, the most common pathological finding on renal biopsy was membranous glomerulonephritis (11 of the 13) and much less commonly minimal change disease (two of 13). The diseases for which transplantation was performed included chronic myeloid leukemia, multiple myeloma, aplastic anemia and acute leukemia.…”
Section: Discussionsupporting
confidence: 80%
“…[16][17][18][19][20][21][22][23][24][25][26][27][28] In all these reports, similar to our series, the most common pathological finding on renal biopsy was membranous glomerulonephritis (11 of the 13) and much less commonly minimal change disease (two of 13). The diseases for which transplantation was performed included chronic myeloid leukemia, multiple myeloma, aplastic anemia and acute leukemia.…”
Section: Discussionsupporting
confidence: 80%
“…[4][5][6][14][15][16][18][19][20][21][22][23][24][25][26][27][28][29] In our series, among seven patients with membranous glomerulonephritis, all five patients with allogeneic transplants had evidence of chronic graft-versushost disease, (in the non-membranous glomerulonephritis cohort, only three out of eight patients had chronic graft-versus-host disease). Importantly, we also present two patients with biopsy proven membranous glomerulonephritis after autologous hematopoietic cell transplantation.…”
Section: Discussionmentioning
confidence: 99%
“…Hepatitis B and C serologies and antinuclear antibody (ANA) titers were within normal limits. The patient began to take prednisone 20 to HUP in July 2003 with dyspnea on exertion, foamy urine, facial edema, and a rash on his face and on both arms for 1 wk. His medications had included CsA for GVHD prophylaxis until 1 mo before presentation.…”
Section: Typical Case Reportsmentioning
confidence: 99%